Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 4
Submit an article Journal homepage
507
Views
21
CrossRef citations to date
0
Altmetric
Original Article: Clinical

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy

Shasha LuDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Yu XuDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Qitian MuDepartment of Hematology, the First Affiliated Hospital, Ningbo University, Ningbo, China
,
Lihong CaoDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Jian ChenDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Zhijuan ZhuDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Yinjun LouDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Haitao MengDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Wenbin QianDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Hongyan TongDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Wenyuan MaiDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Jian HuangDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Wenjuan YuDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
,
Xiaoying ZhaoDepartment of Hematology, the Second Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China
&
Jie JinDepartment of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China;Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, ChinaCorrespondence[email protected]
 show all
Pages 1027-1032 | Received 02 Mar 2014, Accepted 16 Jul 2014, Published online: 19 Aug 2014

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Min-Yue Zhang, Gui-Qi Zhu, Ji-Na Zheng, Zhang Cheng, Sven Van Poucke, Ke-Qing Shi, Hong-Hui Huang, Fang-Yuan Chen & Ming-Hua Zheng. (2017) Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis. Expert Review of Anti-infective Therapy 15:5, pages 503-513.
Read now

Articles from other publishers (20)

Li‐Ping Shui, Yan Zhu, Xiao‐Qin Duan, Yu‐Ting Chen, Li Yang, Xiao‐Qiong Tang, Hong‐Bin Zhang, Qing Xiao, Li Wang, Lin Liu & Xiao‐Hua Luo. (2023) HBsAg (−)/HBsAb (−)/HBeAg (−)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B‐cell lymphoma receiving rituximab based immunochemotherapy. Journal of Medical Virology 95:2.
Crossref
Chia Jie Tan, Rajneesh Kumar, Narendran Koomanan, Wei Sheng Loo, Mohamad Farid, Miriam Tao, Nagavalli Somasundaram, Eileen Poon, Jason Yongsheng Chan, Valerie Shiwen Yang, Esther Chang, Soon Thye Lim, Wan Cheng Chow, Alexandre Chan & Tiffany Tang. (2021) Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:4, pages 332-341.
Crossref
Carmen Ka Man Cheung, Man Fai Law, David Chun Chao, Sunny Hei Wong, Rita Ho, Amelia Chien Wei Chao, Jennifer Wing Yan Lai, Ted Yun Tat Chan, Mark Tsz Kin Tam, Sam Lik Fung Lau & Tommy Ho Chi Tam. (2020) Prevention of hepatitis B virus reactivation in patients with hematological malignancies and resolved hepatitis B virus infection: a systematic review and meta‐analysis. Journal of Digestive Diseases 21:3, pages 160-169.
Crossref
Lan-Ying He, Yu-Lan Wang, Xu Tian & Wei-Qing Chen. (2020) The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy. Medicine 99:14, pages e19647.
Crossref
Manuel Pombo-Suarez & Juan J. Gomez-Reino. 2020. Infections in Systemic Autoimmune Diseases: Risk Factors and Management. Infections in Systemic Autoimmune Diseases: Risk Factors and Management 179 203 .
Tsutomu Nishida, Tokuhiro Matsubara, Takayuki Yakushijin & Masami Inada. (2019) Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers. Hepatology International 13:4, pages 407-415.
Crossref
Rhiannon M. Bath, Brandelyn E. Doering, Michael D. Nailor & Kellie J. Goodlet. (2018) Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review. Annals of Pharmacotherapy 53:3, pages 294-310.
Crossref
Chak Sing Lau, Faith Chia, Leonila Dans, Andrew Harrison, Tsu Yi Hsieh, Rahul Jain, Seung Min Jung, Mitsumasa Kishimoto, Ashok Kumar, Khai Pang Leong, Zhanguo Li, Juan Javier Lichauco, Worawit Louthrenoo, Shue Fen Luo, Rong Mu, Peter Nash, Chin Teck Ng, Bagus Suryana, Linda Kurniaty Wijaya & Swan Sim Yeap. (2019) 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. International Journal of Rheumatic Diseases 22:3, pages 357-375.
Crossref
Wei Ping Liu, Xiu Bin Xiao, Mei Xue, Gui Qiang Wang, Xiao Pei Wang, Yu Qin Song & Jun Zhu. (2019) Prophylactic Use of Entecavir for Lymphoma Patients With Past Hepatitis B Virus Infection: A Randomized Controlled Trial. Clinical Lymphoma Myeloma and Leukemia 19:2, pages 103-108.
Crossref
Hyunsung Park, Do Young Kim, Soo-Jeong Kim, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jae-Woo Song & Jin Seok Kim. (2018) HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma. Cancer Research and Treatment 50:4, pages 1121-1129.
Crossref
Yi-Chia Su, Pei-Chin Lin, Hsien-Chung Yu & Chih-Chien Wu. (2018) Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 74:9, pages 1111-1119.
Crossref
Z. Xu, W. Dai, Y.-T. Wu, B. Arshad, X. Li, H. Wu, H.-R. Chen, K.-N. Wu & L.-Q. Kong. (2018) Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis. European Journal of Cancer Care 27:2, pages e12799.
Crossref
E. Ghrenassia, E. Mariotte & E. Azoulay. 2018. Annual Update in Intensive Care and Emergency Medicine 2018. Annual Update in Intensive Care and Emergency Medicine 2018 579 596 .
Zilin Tang, Xiaodong Li, Shunquan Wu, Yan Liu, Yan Qiao, Dongping Xu & Jin Li. (2017) Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis. Hepatology International 11:5, pages 429-433.
Crossref
Sonali Paul, Aaron Dickstein, Akriti Saxena, Norma Terrin, Kathleen Viveiros, Ethan M. Balk & John B. Wong. (2017) Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta‐analysis. Hepatology 66:2, pages 379-388.
Crossref
Le-Feng Chen, Ying-Qian Mo, Jun Jing, Jian-Da Ma, Dong-Hui Zheng & Lie Dai. (2017) Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation. International Journal of Rheumatic Diseases 20:7, pages 859-869.
Crossref
Jianqiu Wu, Yongping Song, Liping Su, Li Xu, Tingchao Chen, Zhiyun Zhao, Mingzhi Zhang, Wei Li, Yu Hu, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, Zimin Sun, Hai Bai, Tongjian Cui & Jifeng Feng. (2016) Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study. BMC Cancer 16:1.
Crossref
Venessa Pattullo. (2016) Prevention of Hepatitis B reactivation in the setting of immunosuppression. Clinical and Molecular Hepatology 22:2, pages 219-237.
Crossref
Vincent Mallet, Florian van Bömmel, Christopher Doerig, Sven Pischke, Olivier Hermine, Anna Locasciulli, Catherine Cordonnier, Thomas Berg, Darius Moradpour, Heiner Wedemeyer & Per Ljungman. (2016) Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). The Lancet Infectious Diseases 16:5, pages 606-617.
Crossref
Francesca De Nard. (2015) Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs. World Journal of Hepatology 7:3, pages 344.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.